BIOMAT Database Logo BIOMAT Database Logo

Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure. 1984

B Jackson, and P G Matthews, and B P McGrath, and C I Johnston

UI MeSH Term Description Entries
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D013722 Teprotide A synthetic nonapeptide (Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) which is identical to the peptide from the venom of the snake, Bothrops jararaca. It inhibits kininase II and ANGIOTENSIN I and has been proposed as an antihypertensive agent. BPP-9a,Bradykinin-Potentiating Peptide 9a,Nonapeptide-Converting Enzyme Inhibitor,SQ-20881,Bradykinin Potentiating Peptide 9a,Enzyme Inhibitor, Nonapeptide-Converting,Nonapeptide Converting Enzyme Inhibitor,Peptide 9a, Bradykinin-Potentiating
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

B Jackson, and P G Matthews, and B P McGrath, and C I Johnston
Angiotensin converting enzyme inhibition in renovascular hypertension: failure of the stenotic kidney.
February 1984, Lancet (London, England),
B Jackson, and P G Matthews, and B P McGrath, and C I Johnston
Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
September 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
B Jackson, and P G Matthews, and B P McGrath, and C I Johnston
Angiotensin-converting enzyme inhibition in renovascular hypertension: the narrowing gap between functional renal failure and progressive renal atrophy.
January 1990, The Journal of laboratory and clinical medicine,
B Jackson, and P G Matthews, and B P McGrath, and C I Johnston
Angiotensin-converting enzyme inhibition-induced changes in hippurate renography and renal function in renovascular hypertension.
March 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
B Jackson, and P G Matthews, and B P McGrath, and C I Johnston
Angiotensin-converting enzyme inhibition and renovascular disease.
October 1990, The Quarterly journal of medicine,
B Jackson, and P G Matthews, and B P McGrath, and C I Johnston
Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
June 1987, Journal of clinical hypertension,
B Jackson, and P G Matthews, and B P McGrath, and C I Johnston
Angiotensin converting enzyme inhibition improves diagnostic procedures for renovascular hypertension in dogs.
October 1988, Hypertension (Dallas, Tex. : 1979),
B Jackson, and P G Matthews, and B P McGrath, and C I Johnston
[Fetal angiotensin converting enzyme (ACE) inhibition renal failure].
January 2001, Ryoikibetsu shokogun shirizu,
B Jackson, and P G Matthews, and B P McGrath, and C I Johnston
Renographic diagnosis of renovascular hypertension with angiotensin converting enzyme inhibition and furosemide.
December 1991, American journal of hypertension,
B Jackson, and P G Matthews, and B P McGrath, and C I Johnston
Enhancement of screening tests for renovascular hypertension by angiotensin-converting enzyme inhibition.
January 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!